new glp 1 gip Dual GIP/GLP-1 receptor agonists: advances for treating type-2 diabetes Indications for GLP-1/GIP RA Summary

Incretins also activate receptors in the brain that promote feelings of fullness and reduce appetite an added benefit for individuals who need to lose weight

Maintenance: Follow-up sessions may be advised to maintain results

It's a different strategy than using Tesamorelin, but it's built on the same synergistic principle of combining a GHRH with a GHRP

Tesamorelin: FDA-approved in 2010 under the brand name Egrifta for the reduction of excess abdominal fat in HIV-associated lipodystrophy

A JAMA study in May reported that more than 60,500 adolescents and young adults were prescribed a GLP-1 drug in 2023, a nearly 600 percent increase from 2020

The Type A syndrome hyperandrogenism IR (HAIR-AN syndrome) presents with hyperandrogenemia, IR, and AN